{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:42Z","timestamp":1787041662216,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05330-4","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:07:19Z","timestamp":1781874439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An epithelial mesenchymal transition associated gene signature stratifies risk of ulcerative colitis associated colorectal cancer"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-9387","authenticated-orcid":false,"given":"Nevin","family":"Belder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"1","key":"5330_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, et al. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(1):74.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"5330_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00535-005-1744-3","volume":"41","author":"T Hibi","year":"2006","unstructured":"Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol. 2006;41(1):10\u20136.","journal-title":"J Gastroenterol"},{"issue":"10080","key":"5330_CR3","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, et al. Ulcerative colitis. Lancet. 2017;389(10080):1756\u201370.","journal-title":"Lancet"},{"issue":"1","key":"5330_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41389-023-00492-0","volume":"12","author":"RW Zhou","year":"2023","unstructured":"Zhou RW, et al. Molecular mechanisms in colitis-associated colorectal cancer. Oncogenesis. 2023;12(1):48.","journal-title":"Oncogenesis"},{"issue":"3","key":"5330_CR5","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5330_CR6","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1038\/s41598-023-29344-y","volume":"13","author":"M Shahnazari","year":"2023","unstructured":"Shahnazari M, et al. Novel biomarkers for neoplastic progression from ulcerative colitis to colorectal cancer: a systems biology approach. Sci Rep. 2023;13(1):3413.","journal-title":"Sci Rep"},{"issue":"1","key":"5330_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41467-022-35592-9","volume":"14","author":"WK Chatila","year":"2023","unstructured":"Chatila WK, et al. Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. Nat Commun. 2023;14(1):110.","journal-title":"Nat Commun"},{"issue":"2","key":"5330_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10620-011-1890-9","volume":"57","author":"W Gong","year":"2012","unstructured":"Gong W, et al. Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study. Dig Dis Sci. 2012;57(2):503\u20137.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"5330_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.humimm.2013.09.012","volume":"75","author":"GG Song","year":"2014","unstructured":"Song GG, et al. Meta-analysis of differentially expressed genes in primary Sjogren\u2019s syndrome by using microarray. Hum Immunol. 2014;75(1):98\u2013104.","journal-title":"Hum Immunol"},{"issue":"1","key":"5330_CR10","doi-asserted-by":"publisher","first-page":"21246","DOI":"10.1038\/s41598-020-78126-3","volume":"10","author":"KL Sheng","year":"2020","unstructured":"Sheng KL, et al. An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression. Sci Rep. 2020;10(1):21246.","journal-title":"Sci Rep"},{"issue":"1","key":"5330_CR11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1186\/s12885-022-09931-4","volume":"22","author":"P Samadi","year":"2022","unstructured":"Samadi P, et al. An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer. BMC Cancer. 2022;22(1):835.","journal-title":"BMC Cancer"},{"issue":"36","key":"5330_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400595","volume":"11","author":"F Haghayegh","year":"2024","unstructured":"Haghayegh F, et al. Revolutionary point-of-care wearable diagnostics for early disease detection and biomarker discovery through intelligent technologies. Adv Sci (Weinh). 2024;11(36):e2400595.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"5330_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-90025-z","volume":"15","author":"TW Ke","year":"2025","unstructured":"Ke TW, et al. Comprehensive bioinformatic analysis reveals prognostic significance and functional insights of candidate gene expression in colorectal cancer. Sci Rep. 2025;15(1):5659.","journal-title":"Sci Rep"},{"key":"5330_CR14","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.2147\/OTT.S222608","volume":"12","author":"R Huang","year":"2019","unstructured":"Huang R, et al. TIMP1 is a potential key gene associated with the pathogenesis and prognosis of ulcerative colitis-associated colorectal cancer. Onco Targets Ther. 2019;12:8895\u2013904.","journal-title":"Onco Targets Ther"},{"issue":"35","key":"5330_CR15","doi-asserted-by":"publisher","first-page":"37600","DOI":"10.18632\/oncotarget.6067","volume":"6","author":"X Guan","year":"2015","unstructured":"Guan X, et al. Revealing potential molecular targets bridging colitis and colorectal cancer based on multidimensional integration strategy. Oncotarget. 2015;6(35):37600\u201312.","journal-title":"Oncotarget"},{"key":"5330_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.857148","volume":"12","author":"S Wang","year":"2022","unstructured":"Wang S, et al. Search for key genes and functional pathways of ulcerative colitis to colon cancer based on bioinformatics. Front Oncol. 2022;12:857148.","journal-title":"Front Oncol"},{"issue":"D1","key":"5330_CR17","doi-asserted-by":"publisher","first-page":"D138","DOI":"10.1093\/nar\/gkad965","volume":"52","author":"E Clough","year":"2024","unstructured":"Clough E, et al. NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update. Nucleic Acids Res. 2024;52(D1):D138\u201344.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"5330_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"12","key":"5330_CR19","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739\u201340.","journal-title":"Bioinformatics"},{"issue":"W1","key":"5330_CR20","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5330_CR21","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"key":"5330_CR22","first-page":"707","volume":"13","author":"CY Ge","year":"2020","unstructured":"Ge CY, et al. A seven-NF-kappaB-related gene signature may distinguish patients with ulcerative colitis-associated colorectal carcinoma. Pharmgenomics Pers Med. 2020;13:707\u201318.","journal-title":"Pharmgenomics Pers Med"},{"key":"5330_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1086898","volume":"14","author":"Z Pan","year":"2023","unstructured":"Pan Z, et al. Identification of gene signatures associated with ulcerative colitis and the association with immune infiltrates in colon cancer. Front Immunol. 2023;14:1086898.","journal-title":"Front Immunol"},{"key":"5330_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cells14030162","author":"JK Yamamoto-Furusho","year":"2025","unstructured":"Yamamoto-Furusho JK, Gutierrez-Herrera FD. Molecular mechanisms and clinical aspects of colitis-associated cancer in ulcerative colitis. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14030162.","journal-title":"Cells"},{"issue":"3","key":"5330_CR25","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/ibd.21365","volume":"17","author":"T Watanabe","year":"2011","unstructured":"Watanabe T, et al. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis. 2011;17(3):802\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"44","key":"5330_CR26","doi-asserted-by":"publisher","first-page":"16389","DOI":"10.3748\/wjg.v20.i44.16389","volume":"20","author":"M Yashiro","year":"2014","unstructured":"Yashiro M. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol. 2014;20(44):16389\u201397.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5330_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00384-025-05001-w","volume":"40","author":"A Saito","year":"2025","unstructured":"Saito A, et al. Analysis of clinicopathological features and oncological outcomes of ulcerative colitis-associated colorectal cancer based on macroscopic classification. Int J Colorectal Dis. 2025;40(1):223.","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"5330_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/gastro\/goy010","volume":"6","author":"Y Zhen","year":"2018","unstructured":"Zhen Y, Luo C, Zhang H. Early detection of ulcerative colitis-associated colorectal cancer. Gastroenterol Rep (Oxf). 2018;6(2):83\u201392.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"5330_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103269","volume":"84","author":"L Zhang","year":"2025","unstructured":"Zhang L, et al. Colorectal cancer risk in ulcerative colitis: an updated population-based systematic review and meta-analysis. EClinicalMedicine. 2025;84:103269.","journal-title":"EClinicalMedicine"},{"key":"5330_CR30","doi-asserted-by":"crossref","unstructured":"Ikebata A, et al. Background mucosal inflammation affects colorectal cancer prognosis in ulcerative colitis: a nationwide, multicenter study. J Crohns Colitis. 2025.","DOI":"10.1093\/ecco-jcc\/jjaf207"},{"issue":"8","key":"5330_CR31","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/jgh.15919","volume":"37","author":"SH Park","year":"2022","unstructured":"Park SH, Park SH. Personalized medicine in inflammatory bowel disease: perspectives on Asia. J Gastroenterol Hepatol. 2022;37(8):1434\u201345.","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"5330_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/ncponc1187","volume":"5","author":"V Kulasingam","year":"2008","unstructured":"Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol. 2008;5(10):588\u201399.","journal-title":"Nat Clin Pract Oncol"},{"key":"5330_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pbiomolbio.2023.04.002","volume":"180\u2013181","author":"K Mokhtari","year":"2023","unstructured":"Mokhtari K, et al. Colon cancer transcriptome. Prog Biophys Mol Biol. 2023;180\u2013181:49\u201382.","journal-title":"Prog Biophys Mol Biol"},{"issue":"1","key":"5330_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jcmgh.2021.02.003","volume":"12","author":"V Diez-Obrero","year":"2021","unstructured":"Diez-Obrero V, et al. Genetic effects on transcriptome profiles in colon epithelium provide functional insights for genetic risk loci. Cell Mol Gastroenterol Hepatol. 2021;12(1):181\u201397.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"12","key":"5330_CR35","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.3748\/wjg.v20.i12.3164","volume":"20","author":"A Bressenot","year":"2014","unstructured":"Bressenot A. Microscopic features of colorectal neoplasia in inflammatory bowel diseases. World J Gastroenterol. 2014;20(12):3164\u201372.","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"5330_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/den.13387","volume":"31","author":"H Kawachi","year":"2019","unstructured":"Kawachi H. Histopathological diagnosis of ulcerative colitis-associated neoplasia. Dig Endosc. 2019;31(Suppl 1):31\u20135.","journal-title":"Dig Endosc"},{"key":"5330_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1611598","volume":"16","author":"M Wang","year":"2025","unstructured":"Wang M, et al. Multi-omics derivation of a core gene signature for predicting therapeutic response and characterizing immune dysregulation in inflammatory bowel disease. Front Immunol. 2025;16:1611598.","journal-title":"Front Immunol"},{"issue":"6","key":"5330_CR38","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.5009\/gnl230283","volume":"18","author":"YK Jun","year":"2024","unstructured":"Jun YK, et al. Molecular activity of inflammation and epithelial-mesenchymal transition in the microenvironment of ulcerative colitis. Gut Liver. 2024;18(6):1037\u201347.","journal-title":"Gut Liver"},{"issue":"50","key":"5330_CR39","doi-asserted-by":"publisher","first-page":"15240","DOI":"10.1021\/acs.jafc.1c06292","volume":"69","author":"C Cheng","year":"2021","unstructured":"Cheng C, et al. Hyperoside ameliorates DSS-induced colitis through MKRN1-mediated regulation of PPARgamma signaling and Th17\/Treg balance. J Agric Food Chem. 2021;69(50):15240\u201351.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"5330_CR40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12967-021-02943-x","volume":"19","author":"J Huang","year":"2021","unstructured":"Huang J, et al. Lactobacillus paracasei R3 protects against dextran sulfate sodium (DSS)-induced colitis in mice via regulating Th17\/Treg cell balance. J Transl Med. 2021;19(1):356.","journal-title":"J Transl Med"},{"key":"5330_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112217","volume":"134","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li M, Zha A. mTOR promotes an inflammatory response through the HIF1 signaling pathway in ulcerative colitis. Int Immunopharmacol. 2024;134:112217.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"5330_CR42","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/JCI84433","volume":"126","author":"CT Taylor","year":"2016","unstructured":"Taylor CT, et al. Hypoxia-dependent regulation of inflammatory pathways in immune cells. J Clin Invest. 2016;126(10):3716\u201324.","journal-title":"J Clin Invest"},{"issue":"1","key":"5330_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13046-018-0730-6","volume":"37","author":"YH Yeh","year":"2018","unstructured":"Yeh YH, et al. Inflammatory interferon activates HIF-1alpha-mediated epithelial-to-mesenchymal transition via PI3K\/AKT\/mTOR pathway. J Exp Clin Cancer Res. 2018;37(1):70.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"5330_CR44","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1158\/0008-5472.CAN-11-3123","volume":"72","author":"CW Li","year":"2012","unstructured":"Li CW, et al. Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Cancer Res. 2012;72(5):1290\u2013300.","journal-title":"Cancer Res"},{"key":"5330_CR45","doi-asserted-by":"crossref","unstructured":"Nagaraja AS, et al. Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. JCI Insight. 2021; 6(7).","DOI":"10.1172\/jci.insight.149895"},{"issue":"1","key":"5330_CR46","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41392-025-02518-y","volume":"10","author":"W Li","year":"2025","unstructured":"Li W, et al. Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression. Signal Transduct Target Ther. 2025;10(1):420.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5330_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41698-024-00523-y","volume":"8","author":"Y Hu","year":"2024","unstructured":"Hu Y, et al. INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer. NPJ Precis Oncol. 2024;8(1):35.","journal-title":"NPJ Precis Oncol"},{"issue":"10","key":"5330_CR48","doi-asserted-by":"publisher","first-page":"18065","DOI":"10.1002\/jcp.28439","volume":"234","author":"ZL Chen","year":"2019","unstructured":"Chen ZL, et al. INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF-beta signaling pathway. J Cell Physiol. 2019;234(10):18065\u201374.","journal-title":"J Cell Physiol"},{"issue":"1","key":"5330_CR49","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1080\/21655979.2021.1957754","volume":"12","author":"Y Yu","year":"2021","unstructured":"Yu Y, et al. Inhibin beta-A (INHBA) induces epithelial-mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-beta signaling pathway. Bioengineered. 2021;12(1):4681\u201396.","journal-title":"Bioengineered"},{"issue":"1","key":"5330_CR50","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12967-023-04303-3","volume":"21","author":"Q Ping","year":"2023","unstructured":"Ping Q, et al. TGF-beta1 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells. J Transl Med. 2023;21(1):475.","journal-title":"J Transl Med"},{"issue":"1","key":"5330_CR51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13046-025-03527-z","volume":"44","author":"L Liu","year":"2025","unstructured":"Liu L, et al. Crosstalk between heterogeneous cancer-associated fibroblast subpopulations and the immune system in breast cancer: key players and promising therapeutic targets. J Exp Clin Cancer Res. 2025;44(1):263.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5330_CR52","doi-asserted-by":"publisher","first-page":"9387","DOI":"10.1038\/s41467-025-64447-2","volume":"16","author":"J Ma","year":"2025","unstructured":"Ma J, et al. FAP(+) fibroblasts orchestrate tumor microenvironment remodeling in renal cell carcinoma with tumor thrombus. Nat Commun. 2025;16(1):9387.","journal-title":"Nat Commun"},{"key":"5330_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143466","author":"I Belhabib","year":"2021","unstructured":"Belhabib I, et al. Extracellular matrices and cancer-associated fibroblasts: targets for cancer diagnosis and therapy? Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13143466.","journal-title":"Cancers (Basel)"},{"key":"5330_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051480","author":"Y Song","year":"2023","unstructured":"Song Y, et al. COL12A1 acts as a novel prognosis biomarker and activates cancer-associated fibroblasts in pancreatic cancer through bioinformatics and experimental validation. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15051480.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5330_CR55","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s12672-025-03405-2","volume":"16","author":"J Shi","year":"2025","unstructured":"Shi J, et al. Multiomics analysis of COL12A1 as a promising prognostic biomarker for immune-related treatment of gastric cancer. Discov Oncol. 2025;16(1):1876.","journal-title":"Discov Oncol"},{"key":"5330_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/biom13111604","author":"HI Atiya","year":"2023","unstructured":"Atiya HI, et al. Stromal-modulated epithelial-to-mesenchymal transition in cancer cells. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13111604.","journal-title":"Biomolecules"},{"issue":"15","key":"5330_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71126","volume":"14","author":"H Yin","year":"2025","unstructured":"Yin H, et al. CTHRC1 derived from cancer-associated fibroblasts promotes pancreatic cancer progression and metastasis via the LIF-STAT3 pathway. Cancer Med. 2025;14(15):e71126.","journal-title":"Cancer Med"},{"issue":"1","key":"5330_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68109-z","volume":"14","author":"E Li","year":"2024","unstructured":"Li E, Cheung HCZ, Ma S. CTHRC1(+) fibroblasts and SPP1(+) macrophages synergistically contribute to pro-tumorigenic tumor microenvironment in pancreatic ductal adenocarcinoma. Sci Rep. 2024;14(1):17412.","journal-title":"Sci Rep"},{"issue":"16","key":"5330_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35727","volume":"10","author":"Y Bian","year":"2024","unstructured":"Bian Y, et al. Exosomal CTHRC1 from cancer-associated fibroblasts facilitates endometrial cancer progression via ITGB3\/FAK signaling pathway. Heliyon. 2024;10(16):e35727.","journal-title":"Heliyon"},{"issue":"20","key":"5330_CR60","doi-asserted-by":"publisher","first-page":"R1009","DOI":"10.1016\/j.cub.2014.09.036","volume":"24","author":"N Ferrari","year":"2014","unstructured":"Ferrari N, Calvo F. Tumor microenvironment: unleashing metalloproteinases to induce a CAF phenotype. Curr Biol. 2014;24(20):R1009\u201311.","journal-title":"Curr Biol"},{"key":"5330_CR61","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.matbio.2022.06.009","volume":"111","author":"P Duch","year":"2022","unstructured":"Duch P, et al. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma. Matrix Biol. 2022;111:207\u201325.","journal-title":"Matrix Biol"},{"key":"5330_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050495","author":"A Altadill","year":"2021","unstructured":"Altadill A, et al. Relationship between metalloprotease-7 and -14 and tissue inhibitor of metalloprotease 1 expression by mucosal stromal cells and colorectal cancer development in inflammatory bowel disease. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9050495.","journal-title":"Biomedicines"},{"key":"5330_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1185029","volume":"13","author":"Y Du","year":"2023","unstructured":"Du Y, et al. Corrigendum: the epithelial to mesenchymal transition related gene calumenin is an adverse prognostic factor of bladder cancer correlated with tumor microenvironment remodeling, gene mutation, and ferroptosis. Front Oncol. 2023;13:1185029.","journal-title":"Front Oncol"},{"issue":"1","key":"5330_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-21420-9","volume":"15","author":"S Yang","year":"2025","unstructured":"Yang S, Ma C, Zhao Y. SPP1(+) macrophages promote colorectal cancer progression by activating JAK2\/STAT3 signaling pathway. Sci Rep. 2025;15(1):37502.","journal-title":"Sci Rep"},{"issue":"1","key":"5330_CR65","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12885-019-5462-2","volume":"19","author":"TP Sandberg","year":"2019","unstructured":"Sandberg TP, et al. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer. BMC Cancer. 2019;19(1):284.","journal-title":"BMC Cancer"},{"issue":"1","key":"5330_CR66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12672-025-04343-9","volume":"17","author":"X Peng","year":"2025","unstructured":"Peng X, et al. Bioinformatics-based screening and prediction of compounds and antigen epitopes for immune targets with point mutations in colitis-associated colorectal cancer. Discov Oncol. 2025;17(1):189.","journal-title":"Discov Oncol"},{"issue":"1","key":"5330_CR67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12863-022-01065-7","volume":"23","author":"Y Huang","year":"2022","unstructured":"Huang Y, et al. Identification of hub genes and pathways in colitis-associated colon cancer by integrated bioinformatic analysis. BMC Genom Data. 2022;23(1):48.","journal-title":"BMC Genom Data"},{"issue":"1","key":"5330_CR68","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12967-025-06565-5","volume":"23","author":"P Zhou","year":"2025","unstructured":"Zhou P, et al. Unveiling the hidden dance: SPP1 + macrophages identified in ulcerative colitis reveal crosstalk with CHI3L1 + fibroblasts. J Transl Med. 2025;23(1):567.","journal-title":"J Transl Med"},{"issue":"6","key":"5330_CR69","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/MEG.0000000000002349","volume":"34","author":"P Giannos","year":"2022","unstructured":"Giannos P, et al. SPP1 in infliximab resistant ulcerative colitis and associated colorectal cancer: an analysis of differentially expressed genes. Eur J Gastroenterol Hepatol. 2022;34(6):598\u2013606.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"5330_CR70","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2174\/0113862073281374231228041841","volume":"28","author":"J Wang","year":"2025","unstructured":"Wang J, et al. The role of Zuo Jin Wan in modulating the tumor microenvironment of colorectal cancer. Comb Chem High Throughput Screen. 2025;28(3):523\u201332.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"9","key":"5330_CR71","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000721","volume":"15","author":"AM Honan","year":"2024","unstructured":"Honan AM, et al. Stromal-like cells are found in peripheral blood of patients with inflammatory bowel disease and correlate with immune activation state. Clin Transl Gastroenterol. 2024;15(9):e1.","journal-title":"Clin Transl Gastroenterol"},{"key":"5330_CR72","doi-asserted-by":"crossref","unstructured":"Bjorner K, et al. Tumor-stroma ratio in colitis-associated colorectal cancer. Ups J Med Sci. 2025; 130.","DOI":"10.48101\/ujms.v130.13250"},{"issue":"4","key":"5330_CR73","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/ibd\/izae255","volume":"31","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, et al. Stromal cell subsets show model-dependent changes in experimental colitis and affect epithelial tissue repair and immune cell activation. Inflamm Bowel Dis. 2025;31(4):1051\u201366.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"5330_CR74","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology. 2022;162(3):715-730 e3.","journal-title":"Gastroenterology"},{"issue":"7","key":"5330_CR75","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1878-0261.12095","volume":"11","author":"M Suarez-Carmona","year":"2017","unstructured":"Suarez-Carmona M, et al. EMT and inflammation: inseparable actors of cancer progression. Mol Oncol. 2017;11(7):805\u201323.","journal-title":"Mol Oncol"},{"issue":"2","key":"5330_CR76","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.immuni.2023.01.002","volume":"56","author":"L Kong","year":"2023","unstructured":"Kong L, et al. The landscape of immune dysregulation in Crohn\u2019s disease revealed through single-cell transcriptomic profiling in the ileum and colon. Immunity. 2023;56(2):444-458 e5.","journal-title":"Immunity"},{"key":"5330_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125693","author":"J Cheon","year":"2025","unstructured":"Cheon J, et al. Exploring the clinical implication of S100A9 in Ulcerative Colitis and its progression to cancer: a journey from inflammation to cancer. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26125693.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5330_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0339296","volume":"21","author":"Z Sheng","year":"2026","unstructured":"Sheng Z, et al. Identification of hypoxia- and mitophagy-related diagnostic biomarkers for ulcerative colitis based on bioinformatic analysis and machine learning. PLoS ONE. 2026;21(1):e0339296.","journal-title":"PLoS ONE"},{"issue":"45","key":"5330_CR79","doi-asserted-by":"publisher","first-page":"38044","DOI":"10.1039\/D5RA05241F","volume":"15","author":"X Wang","year":"2025","unstructured":"Wang X, et al. Quantitative proteomic and glycoproteomic analysis identifies CLCA1, FBN1, and FGB as potential biomarkers for ulcerative colitis. RSC Adv. 2025;15(45):38044\u201355.","journal-title":"RSC Adv"},{"key":"5330_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110116","volume":"190","author":"M Pawlak","year":"2025","unstructured":"Pawlak M, et al. The critical role of COL1A1 revealed by integrated bioinformatics analysis of differentially-expressed genes in colorectal cancer and inflammatory bowel disease. Comput Biol Med. 2025;190:110116.","journal-title":"Comput Biol Med"},{"issue":"2 Pt 1","key":"5330_CR81","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1158\/1078-0432.CCR-06-0753","volume":"13","author":"T Watanabe","year":"2007","unstructured":"Watanabe T, et al. Gene expression signature and the prediction of ulcerative colitis-associated colorectal cancer by DNA microarray. Clin Cancer Res. 2007;13(2 Pt 1):415\u201320.","journal-title":"Clin Cancer Res"},{"key":"5330_CR82","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ebiom.2018.11.034","volume":"39","author":"AD Beggs","year":"2019","unstructured":"Beggs AD, et al. Validation of epigenetic markers to identify colitis associated cancer: results of module 1 of the ENDCAP-C study. EBioMedicine. 2019;39:265\u201371.","journal-title":"EBioMedicine"},{"key":"5330_CR83","doi-asserted-by":"crossref","unstructured":"Ji Y, et al. Persistent gene activation as a molecular signature of ulcerative colitis progression to colorectal cancer. Dig Dis Sci. 2026.","DOI":"10.1007\/s10620-026-09742-8"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05330-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05330-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05330-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:03:04Z","timestamp":1787040184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05330-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5330"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05330-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was not required for this study, as it was based exclusively on publicly available, de-identified datasets. Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1200"}}